Are Compounded Weight Loss Drugs on Their Way Out?
The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and Zepbound.
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.
Health plans at 1 in 5 large companies cover weight-loss drugs for employees
Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance plans, a new survey shows.
Your employer may start covering weight-loss drugs soon
A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will learn whether they’ll gain such coverage for the coming year during open enrollment,
Companies are more willing to consider covering weight-loss drugs
That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a growing number say they’re open to covering GLP-1 drugs, they’re still in the minority. Some 62% of the firms surveyed said they are “not likely” to begin coverage in the coming year.
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a shortage of the brand-name drug has ended – which means compounding of the medicine must stop.
Only 1 in 5 Large Companies' Health Plans Cover New Weight-Loss Meds for Employees
When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies cover the
Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad
Compounding pharmacies are suing the Food and Drug Administration so they can keep making imitation versions of popular—and lucrative—tirzepatide drugs, namely knockoffs of Mounjaro for diabetes and Zepbound for weight loss.
Popular Weight Loss Drugs To Become More Expensive As Shortage Ends
With the shortage over, compounding pharmacies are no longer allowed to produce the popular weight loss drugs.
Mounjaro is more effective for weight loss than Ozempic. So how does it work? And why does it cost so much?
A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares ...
New York Post12d
Facebook has become the place to sell leftover Ozempic, other weight loss drugs — as NYC sellers take advantage of shortages and high prices
New Yorkers are brazenly reselling prescription diabetic and weight ... “In addition, injectable weight loss drugs are often not covered by insurance, making some patients more likely to pay ...
Washingtonians share how they afford pricey weight loss medications
Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...
Managed Healthcare Executive4d
Are PBMs Putting GLP-1 Drugs on Their Formularies?
PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...
Buyer beware: Off-brand Ozempic and other weight loss drugs carry hidden risks
A pharmacist warns that off-brand Ozempic, Zepbound, and other weight loss products carry undisclosed risks for consumers.
NBC 6 South Florida6d
Surging demand leaves many without crucial diabetes and ADHD medications
The sudden surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a ...